Australia’s largest in vitro fertilization (IVF) provider, ASX-listed Virtus Health, has entered into a binding implementation deed with CapVest at the improved price of A$8.25 (US$5.92) cash per share following…
Australia’s largest in vitro fertilization (IVF) provider, ASX-listed Virtus Health, has entered into a binding implementation deed with CapVest at the improved price of A$8.25 (US$5.92) cash per share following…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


